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Abstract: Profiling the expression levels of genes or proteins in tissues comprising two or more cell
types is commonplace in biological sciences. Such analyses present particular challenges, however,
for example a potential shift in cellular composition, or ‘cellularity’, between specimens. That is,
does an observed change in expression level represent what occurs within individual cells, or does it
represent a shift in the ratio of different cell types within the tissue? This commentary attempts to
highlight the importance of considering cellularity when interpreting quantitative expression data,
using the mammalian testis and a recent study on the effects of phthalate exposure on testis function
as an example.
All tissues comprising two or more cell types are subject to a shift in cellularity. In turn, a change
in tissue cellularity can significantly influence expression level read-outs. This issue is frequently
ignored, or at least not mentioned, when interpreting quantitative expression data. Consequently,
important information may be overlooked or lead to erroneous conclusions. Taking cellularity into
consideration may in some instances also allow for alternative interpretations of the data. To further
illustrate this point this commentary, using the testis as an example, draws from a recent study [1]
published in the March issue of this journal to highlight the importance of considering tissue cellularity.
In their manuscript [1], Li et al. report that in utero exposure to dicyclohexyl phthalate (DCHP)
affect rat fetal Leydig cells and their ability to synthesise vital hormones. This is an interesting study
offering some new insight into how phthalates interfere with fetal testis development and function.
The study joins a significant number of other studies reporting on similar effects of phthalates—namely
reduced testosterone and insulin-like 3 (INSL3) expression and the formation of Leydig cell aggregates
resulting in phenotypic manifestations in androgen- and INSL3-responsive tissues—often collectively
referred to as the “phthalate syndrome” [2]. The fact that DCHP exposure can affect male reproductive
development has been known for some time, but Li and co-workers also wanted to elucidate further
its direct effect on fetal Leydig cells. Based on experimental data, one of the conclusions drawn was
that “in utero exposure to DCHP affects the expression levels of fetal Leydig cell steroidogenic genes”.
This may be so, but considering testicular cellularity after phthalate exposure, the data may also allow
for alternative interpretations.
The mammalian testis is a complex organ comprising more than ten different cell types from early
development [3]. Thus, cellularity has been highlighted as an important parameter to consider when
quantifying expression levels in the testis [4,5] and is sometimes explicitly addressed [6–9]. The fact is
that altered quantitative expression data from multicellular tissues may represent either (i) a bona fide
change in expression levels within individual cells, or (ii) reflect a shift in the ratio between different
cell types. Fortunately, Li and co-workers carefully characterised the histopathological consequence
of DCHP exposure, which revealed an altered Leydig cell morphology, but unaltered Leydig cell
numbers [1]. Based on the latter observation, one could infer that testicular cellularity was relatively
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unchanged, at least pertaining to the Leydig cells and thus, that the lower expression of Leydig
cell-specific steroidogenic genes was due to downregulation of gene transcription. Based on the former
observation, however, a significant shift in cellularity may have occurred and transcription potentially
not affected per se.
The genes assessed by RT-qPCR were for the most part downregulated in the higher dosed animals,
or unchanged as in the case of Cyp11a1. Other Leydig cell-specific genes such as Insl3, Star and Hsd3b1
were significantly suppressed and notably, no genes were shown to be upregulated. The fact that
Cyp11a1 was the only Leydig cell-specific gene not affected could suggest an alternative mode of
action regarding the effects of DCHP on the fetal testis. Since Cyp11a1 is one of the earliest markers
expressed by immature Leydig cells, its expression without concomitant expression of markers of more
mature Leydig cells such as Insl3, could suggest that DCHP exposure causes a loss of mature Leydig
cells and that majority of the Leydig cell are more immature. Thus, it would have been interesting
to include additional Leydig cell markers in the analysis, not least Delta-like 1 homolog (Dlk1),
which has been shown to be a marker for immature Leydig cells, but—as opposed to Cyp11a1—lost in
mature, Insl3-expressing Leydig cells [10]. Previous studies have in fact shown abnormal positioning,
and perhaps disrupted differentiation, of rat Leydig cells in response to phthalate exposure [11,12],
but notably also affecting Cyp11a1 [13].
This commentary has by no means been, and was not intended as an exhaustive review of the
testis-related molecular effects caused by phthalate exposure. The testis, and the study by Li and
co-workers, served chiefly to highlight the importance of taking tissue cellularity into account when
inferring biological relevance from quantitative expression data. It is clear from a large body of
evidence that phthalates affect testis function and numerous studies have shown a clear reduction in
testosterone and INSL3 levels following in utero exposure, with subsequent consequences for male
reproductive health [14,15]. But whether various phthalates directly dysregulate gene expression or
affect Leydig cell differentiation and maintenance more broadly, remains somewhat obscure. Of course,
one might argue that it doesn’t really matter if it is gene expression or Leydig cell differentiation that
causes a reduced level of testosterone. The end result is still the same; androgen insufficiency and
feminised male offspring. Similar arguments could most likely be made for many other tissues under
various situations. But arguing that it doesn’t really matter whether curiosity or malevolence killed the
cat—the cat remains dead—is somewhat unsatisfactory. And I, for one, can imagine many scenarios
where it actually matters deeply.
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